144 related articles for article (PubMed ID: 35466461)
1. Management and outcomes of hydronephrosis in patients with metastatic extramammary Paget's disease: A retrospective analysis.
Fusumae T; Fukuda K; Hirai I; Nakamura Y; Kobayashi K; Tanese K; Matsumoto K; Iwata T; Funakoshi T
J Dermatol; 2022 Aug; 49(8):787-791. PubMed ID: 35466461
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of lymph node dissection in the treatment of extramammary Paget's disease: A single-institution study.
Tsutsui K; Takahashi A; Muto Y; Mizuta H; Jinnai S; Nakama K; Ogata D; Namikawa K; Yamazaki N
J Dermatol; 2020 May; 47(5):512-517. PubMed ID: 32157716
[TBL] [Abstract][Full Text] [Related]
3. Brain metastasis from extramammary Paget's disease.
Hanyu T; Fujitani S; Ito A; Mizutani N
Nagoya J Med Sci; 2020 Nov; 82(4):791-798. PubMed ID: 33311809
[TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal cancer and bilateral hydronephrosis resulted in a high risk of ureteral stent failure.
Ohtaka M; Kawahara T; Takamoto D; Mochizuki T; Hattori Y; Teranishi JI; Makiyama K; Miyoshi Y; Yumura Y; Yao M; Uemura H
BMC Urol; 2018 May; 18(1):35. PubMed ID: 29739370
[TBL] [Abstract][Full Text] [Related]
5. Serum Cytokeratin 18 as a Metastatic and Therapeutic Marker for Extramammary Paget's Disease.
Urano-Takaoka M; Sumida H; Miyagawa T; Awaji K; Nagai K; Omatsu J; Miyake T; Sato S
Acta Derm Venereol; 2022 Jan; 102():adv00636. PubMed ID: 34904690
[TBL] [Abstract][Full Text] [Related]
6. Extramammary Paget's Disease: Diagnosis, Pathogenesis, and Treatment with Focus on Recent Developments.
Ishizuki S; Nakamura Y
Curr Oncol; 2021 Aug; 28(4):2969-2986. PubMed ID: 34436026
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes of advanced/metastatic extramammary Paget's disease in Korean patients: KCSG-RC20-06.
Sohn BS; Kim J; Kim M; Hong JY; Lee J; Park SE; Kim H; Lee HJ; Kang EJ; Lee SI; Lee IH; Huh SJ; Jo J; Kim HY
Cancer Med; 2023 Jul; 12(14):15159-15175. PubMed ID: 37264748
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of docetaxel as first-line chemotherapy for metastatic extramammary Paget's disease.
Yoshino K; Fujisawa Y; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Ohara K
J Dermatol; 2016 Jun; 43(6):633-7. PubMed ID: 26603144
[TBL] [Abstract][Full Text] [Related]
9. The Outcome of Chemotherapy for Metastatic Extramammary Paget's Disease.
Hashimoto H; Kaku-Ito Y; Furue M; Ito T
J Clin Med; 2021 Feb; 10(4):. PubMed ID: 33673310
[TBL] [Abstract][Full Text] [Related]
10. Survival analysis of extramammary Paget's disease (EMPD) in a tertiary hospital in Taiwan.
Chang YW; Ma H; Liao WC
World J Surg Oncol; 2021 Apr; 19(1):110. PubMed ID: 33845845
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the biomarkers for targeted therapies in primary extra-mammary and mammary Paget's disease.
Gatalica Z; Vranic S; Krušlin B; Poorman K; Stafford P; Kacerovska D; Senarathne W; Florento E; Contreras E; Leary A; Choi A; In GK
Cancer Med; 2020 Feb; 9(4):1441-1450. PubMed ID: 31899853
[TBL] [Abstract][Full Text] [Related]
12. Novel ex vivo disease model for extramammary Paget's disease using the cancer tissue-originated spheroid method.
Arita T; Kondo J; Kaneko Y; Tsutsumi M; Kanemaru M; Matsui M; Arakawa Y; Katoh N; Inoue M; Asai J
J Dermatol Sci; 2020 Sep; 99(3):185-192. PubMed ID: 32800410
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of treatment options for extramammary Paget's disease: a SEER database analysis.
Ma X; Li Y
Transl Cancer Res; 2021 Jun; 10(6):2873-2881. PubMed ID: 35116597
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological characteristics, management and outcome of metastatic penoscrotal extramammary Paget's disease.
Zhu Y; Ye DW; Yao XD; Zhang SL; Dai B; Zhang HL; Shen YJ; Mao HR
Br J Dermatol; 2009 Sep; 161(3):577-82. PubMed ID: 19438449
[TBL] [Abstract][Full Text] [Related]
15. Weekly docetaxel monotherapy for metastatic extramammary Paget's disease: Retrospective single-institute analysis.
Nakamura Y; Tanese K; Hirai I; Fukuda K; Kawakami Y; Amagai M; Funakoshi T
J Dermatol; 2020 Apr; 47(4):418-422. PubMed ID: 32020662
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of low-dose 5-fluorouracil/cisplatin therapy for invasive extramammary Paget's disease.
Kato H; Watanabe S; Kariya K; Nakamura M; Morita A
J Dermatol; 2018 May; 45(5):560-563. PubMed ID: 29446148
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel Combined With Cisplatin for Metastatic Extramammary Paget Disease.
Cai H; Xu W; Yu B; Li X; Zhu L; Xu Z; Zhou J; Zheng Y; Zou Q; Zeng Y; Wang X; Xu T
Clin Genitourin Cancer; 2018 Aug; 16(4):e899-e901. PubMed ID: 29685612
[TBL] [Abstract][Full Text] [Related]
18. Extramammary Paget's disease: what do we know and how do we treat?
Adashek JJ; Leonard A; Nealon SW; Krishnan A; Mosiello GC; Dhillon J; Spiess PE
Can J Urol; 2019 Dec; 26(6):10012-10021. PubMed ID: 31860417
[TBL] [Abstract][Full Text] [Related]
19. Modified weekly regimen of cisplatin, epirubicin and paclitaxel induced a durable response in two cases of metastatic extramammary Paget's disease.
Hirai I; Funakoshi T
J Dermatol; 2017 Oct; 44(10):1148-1151. PubMed ID: 28406527
[TBL] [Abstract][Full Text] [Related]
20. Radiation therapy for lymph node metastasis from extramammary Paget's disease.
Hata M; Koike I; Wada H; Minagawa Y; Kasuya T; Matsui T; Suzuki R; Takano S; Inoue T
J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):873-7. PubMed ID: 23663098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
